Product Details: Tirzepatide
Tirzepatide is a synthetic peptide for controlled laboratory use. It is built from a long chain of amino acids arranged in a specific sequence. This structure allows it to interact with defined biological targets during experimental work. [1] It is designed with receptor selectivity in mind, particularly for metabolic signaling pathways. [2]
Take note: Lyophilized peptide with a higher mass may require increased solvent volume.
Low dilution can leave visible residue.
Chemical Properties
- Molecular Formula: C225H348N48O68
- Molecular Weight: 4813.45 g/mol
- CAS Number: 2023788-19-2
- IUPAC / Code Name: LY-3298176
- Synonyms: Tirzepatide, LY3298176, OYN3CCI6QE
Mechanism of Action
is engineered to interact with both:
- glucose-dependent insulinotropic polypeptide (GIP) receptor
- glucagon-like peptide-1 (GLP-1) receptor
This dual activity makes it different from single-pathway peptides. It allows researchers to observe combined receptor signaling in one model instead of separating pathways. [3]
In published studies, this compound is often used to examine how coordinated receptor activation affects glucose-related signaling and downstream cellular responses. [2][3]
Research Application
Tirzepatide is used in studies that look at:
- dual incretin receptor signaling behavior
- glucose-regulated cellular response systems
- pancreatic cell pathway activity
- hormone interaction models involving GLP-1 and GIP
It is also used when comparing single vs dual receptor agonists in controlled experiments.
Why Choose BehemothLabz
We, BehemothLabz, are a place where quality meets trust and excellence. We not only offer RAD 150 for sale but also ensure the following:
– Each batch is checked before release
– 1st party + 3rd party COA available
– Clean labeling, no hidden data
– Stable supply for repeat experiments
Support is direct: support@behemothLabz.com | (307) 429-0990.
Disclaimer: This information is for educational purposes. We do not allow the human consumption of our products. All our products are sold for laboratory and research experiments.
Please make sure you go through the Terms and Conditions. Please research the scientific uses of this product before making any purchases. Make note that the packaging and labels of the product may differ from those shown on the website.
References
[1] National Center for Biotechnology Information. (n.d.). Tirzepatide (Compound Summary). PubChem.
https://pubchem.ncbi.nlm.nih.gov/compound/Tirzepatide
[2] Coskun, T., Sloop, K. W., Loghin, C., Alsina-Fernandez, J., Urva, S., Bokvist, K. B., … & Haupt, A. (2018).
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus.
Science Translational Medicine, 10(467), eaat9939.
https://doi.org/10.1126/scitranslmed.aat9939
[3] Frias, J. P., Nauck, M. A., Van J., Kutner, M. E., Cui, X., Benson, C., … & Milicevic, Z. (2018).
Efficacy and safety of LY3298176, a dual GIP and GLP-1 receptor agonist.
The Lancet, 392(10160), 2180–2193.
https://doi.org/10.1016/S0140-6736(18)32260-8
